Gilead resolves warning letter form US regulatory agency
NEW YORK (AP) —Gilead Sciences Inc. announced that the manufacturing issues highlighted in the FDA warning letter in September have
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine